EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells

Giovanna Weykopf iD, Wendy A Bickmore iD, Simon C Biddie, Elias T Friman iD

PLOS Genetics · 17.07.2026 · 22 (7) · e1012222

DOI: 10.1371/journal.pgen.1012222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 17.07.2026. Verfasst von Giovanna Weykopf und 3 weiteren Autor:innen. Beteiligte Einrichtung: MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Enhancer Elements, Genetic, SARS-CoV-2, Lung. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Foundation, Academy of Medical Sciences, Chief Scientist Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Common genetic variants contribute to risk for complex human diseases. However, despite thousands of associations, variants modulating disease risk and their functional impact remain largely unknown. This includes SARS-CoV-2 infection, where outcomes range from asymptomatic to fatal. Most genetic risk variants associated with COVID-19 disease, identified through genome wide association studies, are located in the non-coding genome and may function by altering gene expression in disease-relevant cells and tissues. To address this at scale, we tested >4800 severe COVID-19-associated variants to determine the impact of individual variants and variant combinations on regulatory activity using Self-Transcribing Active Regulatory Region sequencing, a massively-parallel reporter assay. Focusing on variants that may have their impact in the lung, in a lung epithelial cell line (A549) we identify 166 variants within active sequences, of which 29 modulate activity allele-specifically. Evaluating variant combinations, we observe both additive and non-additive effects on regulatory activity. We employ state-of-the-art deep learning models to interpret allele-specific variant effects on regulatory activity and endogenous genomic features. Our work provides a set of prioritised severe COVID-19-associated variants that modulate regulatory activity in lung epithelial cells, candidate transcription factors, and candidate target genes with potential to be disease modifying.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Enhancer Elements, GeneticSARS-CoV-2LungHumansGenome-Wide Association StudyA549 CellsGenetic Predisposition to DiseaseGenes, ReporterAllelesGenetic VariationEpithelial CellsPolymorphism, Single Nucleotide

Autor:innen und Institutionen

  • MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
  • Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.

ORCID-Profile: Giovanna Weykopf, Wendy A Bickmore, Elias T Friman

Förderung

  • Medical Research Foundation
  • Academy of Medical Sciences
  • Chief Scientist Office

Zitieren

APA

Weykopf, G., Bickmore, W. A., Biddie, S. C., & Friman, E. T. (2026). Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells. PLOS Genetics, 22(7), e1012222. https://doi.org/10.1371/journal.pgen.1012222

Vancouver

Weykopf G, Bickmore WA, Biddie SC, Friman ET. Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells. PLOS Genetics. 2026;22(7):e1012222. doi:10.1371/journal.pgen.1012222

BibTeX
@article{Weykopf2026,
  author = {Weykopf, Giovanna and Bickmore, Wendy A and Biddie, Simon C and Friman, Elias T},
  title = {Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells},
  journal = {PLOS Genetics},
  year = {2026},
  volume = {22},
  number = {7},
  pages = {e1012222},
  doi = {10.1371/journal.pgen.1012222}
}
Kostenlos starten →